Protagenic Therapeutics, Inc. (OTCPK: PTIX)
Health Care · Biotechnology · US
$0.36
+16.32% today · -87.1% 1Y
Protagenic Therapeutics, Inc. (OTCPK: PTIX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $651.67K and employs 1 people.
Over the last twelve months the share price has lost 87.1%, trading between 0.13 and 6.20.
Tweenvest scores Protagenic Therapeutics, Inc. across four factors: quality 26/100. Its strongest factor is quality.
PTIX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $651.67K
- Revenue (TTM)
- —
- P/E
- 0.61
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $6.20
- 52-week low
- $0.13
- Avg volume (3M)
- —
- Shares outstanding
- 1.81M
- Employees
- 1
- Next earnings
- —
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
- ISIN
- US74365N3017
- Founded
- 2004
- Listed since
- Apr 27, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.80 | +0.00% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $444.99 | +0.62% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.10 | -0.45% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.50 | -0.06% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €903.40 | +2.75% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $154.84 | -2.51% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.